Atlas Trials

Progressive Disease

14 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Progressive Disease

RecordFirmDate
Assessment of Retreatment With Lutathera® in Patients With New Progression of Intestinal Well-differenciated NET (NCT04954820)Institut du Cancer de Montpellier - Val d'Aurelle2021-10-18
CPI-613 and Hydroxychloroquine for Patients With High Risk Myelodysplastic Syndrome (NCT03929211)Wake Forest University Health Sciences2021-05-01
Anakinra in Preventing Severe Chimeric Antigen Receptor T-Cell Related Encephalopathy Syndrome in Patients With Recurrent or Refractory Large B-cell Lymphoma (NCT04205838)Jonsson Comprehensive Cancer Center2020-03-04
Pembrolizumab Plus Autologous Dendritic Cell Vaccine in Patients with PD-L1 Negative Advanced Mesothelioma Who Have Failed Prior Therapies (NCT03546426)Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS2019-12-12
sEphB4-HSA in Treating Patients With Metastatic Castration-Resistant Prostate Cancer (NCT04033432)Northwestern University2019-09-20
Axitinib and Avelumab in Treating Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma (NCT03990571)M.D. Anderson Cancer Center2019-07-22
Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer (NCT04017650)M.D. Anderson Cancer Center2019-06-14
Modified Immune Cells (CD19-CD22 CAR T Cells) in Treating Patients With Recurrent or Refractory CD19 Positive, CD22 Positive Leukemia or Lymphoma (NCT04029038)M.D. Anderson Cancer Center2019-05-15
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer (NCT03154190)Stanford University2017-08-08
Activity and Safety Study of BKM120 in Monotherapy in Patient With Metastatic Head and Neck Cancer Recurrent or Progressive (NCT01737450)Centre Leon Berard2013-01-01

Track Progressive Disease automatically

Every clearance here is in the API, with alerts when new ones post.